The BMC Diversity Initiative including SyNergy has invited three distinguished Munich-based scientists to present their current research in translational optoacoustics (Miguel Pleitez), lipid metabolism and metabolic diseases (Susanna Hofmann), and oncolytic virus-based cancer immunotherapeutics (Jennifer Altomonte). They will also share insights into the key experiences and challenges that have defined their careers in research.